We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

LabCorp to Acquire Dianon Systems

By HospiMedica staff writers
Posted on 20 Nov 2002
In a move to increase its presence in the cancer diagnostic testing market, Laboratory Corporation of America (LabCorp, Burlington, NC, USA) has agreed to acquire Dianon Systems, Inc. (Stratford, CT, USA).

Under the terms of the agreement, LabCorp will purchase all of the outstanding shares of Dianon for US$47.50 per share in cash and will acquire the company through the merger of a newly formed wholly-owned subsidiary of LabCorp with Dianon. LabCorp expects to realize an estimated $35 million in annual cost savings synergies by year-end 2005.

Dianon is a leading US provider of anatomic pathology and oncology testing services, with a focus on the outpatient market. Approximately 1,100 employees process more than 8,000 samples per day in one main testing facility and four regional labs. Dianon had 2001 revenues of approximately $126 million, and revenues of approximately $141 million for the nine-month period ended September 30, 2002.

"We are truly excited to have reached an agreement with this premier oncology testing laboratory,” said Thomas P. Mac Mahon, CEO of LabCorp. "More and better cancer diagnostics will continue to have a profound impact on patient care in the coming years. Combining LabCorp and Dianon will improve access to today's valuable cancer testing methods.”




Related Links:
LabCorp
Dianon

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Phototherapy Eye Protector
EyeMax2
New
Hospital Bed
Alphalite

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024